Merit Medical Systems/$MMSI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Merit Medical Systems
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Ticker
$MMSI
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7,400
ISIN
US5898891040
Website
MMSI Metrics
BasicAdvanced
$5.5B
45.51
$2.04
0.85
-
Price and volume
Market cap
$5.5B
Beta
0.85
52-week high
$111.45
52-week low
$82.35
Average daily volume
522K
Financial strength
Current ratio
4.871
Quick ratio
3.111
Long term debt to equity
56.581
Total debt to equity
57.242
Interest coverage (TTM)
5.56%
Profitability
EBITDA (TTM)
273.889
Gross margin (TTM)
47.80%
Net profit margin (TTM)
8.81%
Operating margin (TTM)
11.92%
Effective tax rate (TTM)
20.40%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
4.31%
Return on equity (TTM)
9.16%
Valuation
Price to earnings (TTM)
45.513
Price to revenue (TTM)
3.907
Price to book
3.84
Price to tangible book (TTM)
11.3
Price to free cash flow (TTM)
30.451
Free cash flow yield (TTM)
3.28%
Free cash flow per share (TTM)
304.75%
Growth
Revenue change (TTM)
8.19%
Earnings per share change (TTM)
17.19%
3-year revenue growth (CAGR)
8.03%
10-year revenue growth (CAGR)
10.32%
3-year earnings per share growth (CAGR)
34.94%
10-year earnings per share growth (CAGR)
13.41%
What the Analysts think about MMSI
Analyst ratings (Buy, Hold, Sell) for Merit Medical Systems stock.
Bulls say / Bears say
Merit Medical Systems reported a 7.9% increase in revenue for 2024, indicating strong sales growth. (quiverquant.com)
The company's non-GAAP gross margin improved to 51.7% in 2024 from 50.4% in 2023, reflecting enhanced operational efficiency. (biospace.com)
Merit Medical's Altman Z-score of 4.82 places it in the 'Safe Zone,' indicating strong financial health and low bankruptcy risk. (gurufocus.com)
The company's debt-to-revenue ratio stands at 0.60, which may raise concerns about its leverage levels. (gurufocus.com)
Merit Medical's operating income from the Endoscopy segment decreased to $5.5 million in 2024 from $9.5 million in 2023, indicating a decline in this business area. (publicnow.com)
The company's research and development expenses increased by 5.7% in 2024, which could impact profitability if not offset by corresponding revenue growth. (publicnow.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
MMSI Financial Performance
Revenues and expenses
MMSI Earnings Performance
Company profitability
MMSI News
AllArticlesVideos
Merit Medical Acquires Biolife Delaware, L.L.C.
GlobeNewsWire·1 month ago
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
GlobeNewsWire·2 months ago
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Merit Medical Systems stock?
Merit Medical Systems (MMSI) has a market cap of $5.5B as of June 27, 2025.
What is the P/E ratio for Merit Medical Systems stock?
The price to earnings (P/E) ratio for Merit Medical Systems (MMSI) stock is 45.51 as of June 27, 2025.
Does Merit Medical Systems stock pay dividends?
No, Merit Medical Systems (MMSI) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Merit Medical Systems dividend payment date?
Merit Medical Systems (MMSI) stock does not pay dividends to its shareholders.
What is the beta indicator for Merit Medical Systems?
Merit Medical Systems (MMSI) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.